Maj Hedtjärn has decided to resign from her position as Chief Operating Officer and Head of R&D Operations. She will leave Scandion Oncology no later than December 31, 2022.
Scandion Oncology (Scandion), announces that Maj Hedtjärn, Chief Operating Officer, Head of R&D Operations and member of Executive Management, has decided to resign from her position to pursue new opportunities outside Scandion. Maj Hedtjärn will leave Scandion no later than December 31, 2022, allowing the company sufficient time to plan the optimal future setup for handling her tasks and responsibilities.